Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma

Bone Marrow Transplant. 2020 Dec;55(12):2331-2334. doi: 10.1038/s41409-020-0942-1. Epub 2020 May 13.

Richard J Lin^#^{1

2}, Caleb Ho^#³, Sean M Devlin⁴, Josel D Ruiz⁵, Molly A Maloy⁵, Gunjan L Shah^{5

6}, Miguel-Angel Perales^{5

6}, Parastoo B Dahi^{5

6}, Sergio A Giralt^{5

6}, Michael Scordo^{5

6}, Heiko Schöder^{6

7}, Paul A Hamlin^{6

8}, Allison M Sigler³, Ahmet Dogan^{6

3}, Craig S Sauter^{5

6}

¹ Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. linr@mskcc.org.
² Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY, USA. linr@mskcc.org.
³ Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁸ Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

^# Contributed equally.

No abstract available

Publication types